FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
NurExone Biologic Inc. Stock AnalysisComprehensive stock analysis for NurExone Biologic Inc. (NRX.V) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisNRX.V
NRX.V
NurExone Biologic Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
NRX.V
Home🔹Stocks🔹NurExone Biologic Inc.

NurExone Biologic Inc.

FRC Coverage
NRX.V•TSXV

NurExone Biologic Inc.

FRC Coverage
NRX.V•TSXV
Sentiment

Your view on NRX.V

Sentiment
Your view
NRX.V
NurExone Biologic Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
NRX.V
Company Overview

Overview

What the company does, where it operates, and who runs it.

*NurExone Biologic Inc. has paid FRC a fee for research coverage and distribution of reports.

About NurExone Biologic Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Dr. Lior Shaltiel
Headquarters
1 First Canadian Place Suite 1600 100 King Street West, Toronto, ON, CA
Industry
Biotechnology
Sector
Healthcare
CEO
Dr. Lior Shaltiel
Headquarters
1 First Canadian Place Suite 1600 100 King Street West, Toronto, ON, CA
Description

NurExone Biologic Inc., operates as a pharmaceutical technology company. It is developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. The company was founded in 2020 and is based in Toronto, Canada.

FRC Research
Buy
Fair Value Estimate
CAD$2.00

A Potential Breakthrough in Spinal Cord and Optic Nerve Injury Treatment

Report · Dec 16, 2024

Sign in to view

FRC Research
Buy
Fair Value Estimate
CAD$2.00

A Potential Breakthrough in Spinal Cord and Optic Nerve Injury Treatment

Report · Dec 16, 2024

Sign in to view

Infographics

Visual summary of the business at a glance.

FRC Research

Research Reports

FRC analyst coverage and recommendations.

Past Reports

Historical coverage archive.

Analyst Notes

Ongoing commentary and updates from FRC analysts.

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News